FOXO3 and coronary artery disorder: The present study is the first to quantify the protection against mortality in a large, well‐powered, prospective cohort study of populations of contrasting ethnicities, and to demonstrate that CHD is the main clinical cause of death driving the strong survival advantage seen in carriers of the major longevity‐associated FOXO3 allele.